Highlights from the @ACRheum Kawasaki Disease Guidelines
🥇IVIG is mainstay therapy (2 g/kg)
👶🏼 Use ASA in acute KD
🗣Refractory cases may require steroids or additional immunosuppression
🫀Get echos on all patients to assess for coronary aneurysms
🥇IVIG is mainstay therapy (2 g/kg)
👶🏼 Use ASA in acute KD
🗣Refractory cases may require steroids or additional immunosuppression
🫀Get echos on all patients to assess for coronary aneurysms
